[Managing late-effects after allogeneic stem cell transplantation in children: recommendations from the SFGM-TC].

Date publication

août 2014

Journal

Pathologie-biologie

Auteurs

Membres identifiés du Cancéropôle Est :
Dr POCHON Cécile

Tous les auteurs :
de Berranger E, Michel G, Fahd M, Gandemer V, Jubert C, Marie-Cardine A, Pochon C, Rohrlich PS, Sirvent A, Cartigny M, Deschildre A, Yakoub-Agha I,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/24973860

Résumé

In this report, we address the issue of late-effects after allogeneic stem cell transplantation in children. In an effort to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the fourth annual series of workshops which brought together practitioners from all member centers and took place in September 2013 in Lille.

Mots clés

Allogeneic stem cell transplantation, Greffe de cellules souches hématopoïétiques, Late-effects, Long terme, Long-term, Pediatrics, Pédiatrie, Survivants, Survivors, Séquelles

Référence

Pathol Biol (Paris). 2014 Aug;62(4):212-7